Bio Historical Income Statement
| TECH Stock | USD 71.05 2.33 3.39% |
Historical analysis of Bio Techne income statement accounts such as Operating Income of 107.9 M, Ebit of 110.6 M, EBITDA of 343 M or Cost Of Revenue of 405.3 M can show how well Bio Techne Corp performed in making a profits. Evaluating Bio Techne income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bio Techne's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Bio Techne Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bio Techne Corp is a good buy for the upcoming year.
Bio |
About Bio Income Statement Analysis
Bio Techne Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bio Techne shareholders. The income statement also shows Bio investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Bio Techne Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Bio Techne Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Bio Techne Corp minus its cost of goods sold. It is profit before Bio Techne operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bio Techne Corp. It is also known as Bio Techne overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Bio Techne Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Bio Techne Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Bio Techne's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bio Techne Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. As of now, Bio Techne's Other Operating Expenses is increasing as compared to previous years. The Bio Techne's current EBITDA is estimated to increase to about 343 M, while Operating Income is projected to decrease to under 107.9 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 1.1B | 1.1B | 1.2B | 1.2B | Depreciation And Amortization | 101.1M | 107.2M | 111.7M | 117.3M |
Bio Techne income statement Correlations
Click cells to compare fundamentals
Bio Techne Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bio Techne income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 82.7M | 87.7M | 101.1M | 107.2M | 111.7M | 117.3M | |
| Total Revenue | 738.7M | 931.0M | 1.1B | 1.1B | 1.2B | 1.2B | |
| Gross Profit | 483.2M | 632.9M | 756.5M | 769.8M | 773.1M | 811.7M | |
| Other Operating Expenses | 581.3M | 693.7M | 809.0M | 837.8M | 952.4M | 1000.0M | |
| Operating Income | 74.7M | 149.5M | 296.6M | 298.9M | 206.7M | 107.9M | |
| Ebit | 74.7M | 170.7M | 319.0M | 353.3M | 215.0M | 110.6M | |
| Ebitda | 157.4M | 258.5M | 420.1M | 460.6M | 326.7M | 343.0M | |
| Cost Of Revenue | 255.5M | 298.2M | 349.1M | 366.9M | 386.0M | 405.3M | |
| Total Operating Expenses | 325.8M | 395.6M | 459.9M | 470.9M | 563.0M | 591.2M | |
| Income Before Tax | 276.5M | 148.2M | 301.4M | 338.7M | 185.7M | 114.4M | |
| Total Other Income Expense Net | 201.8M | (89.1M) | 4.8M | 39.7M | (21.0M) | (19.9M) | |
| Net Income | 229.3M | 140.4M | 272.1M | 285.3M | 168.1M | 87.3M | |
| Income Tax Expense | 47.2M | 8.6M | 38.3M | 53.2M | 17.6M | 27.4M | |
| Research Development | 65.2M | 70.6M | 87.1M | 92.5M | 96.7M | 101.5M | |
| Interest Expense | 19.2M | 14.0M | 11.3M | 11.2M | 15.7M | 16.5M | |
| Selling General Administrative | 240.9M | 289.9M | 339.0M | 352.4M | 396.8M | 416.7M | |
| Net Income Applicable To Common Shares | 229.1M | 140.4M | 272.1M | 285.3M | 328.1M | 344.5M | |
| Net Income From Continuing Ops | 229.3M | 139.6M | 263.1M | 285.4M | 168.1M | 160.6M | |
| Non Operating Income Net Other | 138.3M | (75.2M) | 16.1M | 50.9M | 58.6M | 61.5M | |
| Tax Provision | 47.2M | 8.6M | 38.3M | 53.2M | 17.6M | 24.5M | |
| Interest Income | 605K | 473K | 794K | 3.4M | 3.3M | 3.5M | |
| Net Interest Income | (18.6M) | (13.5M) | (10.5M) | (7.8M) | (12.4M) | (13.0M) | |
| Selling And Marketing Expenses | 19.7M | 35.0M | 33.8M | 25.9M | 69.5M | 40.4M | |
| Reconciled Depreciation | 82.7M | 87.7M | 101.1M | 107.2M | 111.7M | 95.3M |
Currently Active Assets on Macroaxis
When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.32) | Dividend Share 0.32 | Earnings Share 0.95 | Revenue Per Share 7.424 | Quarterly Revenue Growth 0.045 |
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.